INVESTORS
11 px font size 12 px font size 14 px font size
APOLLO NEWSLETTER
Professor Paul
Zimmet
AO
Head of
International Diabetes Institute, Melbourne
"The data that I have seen so far makes this one of the most forward looking and best prospects of an oral insulin"
Click here to see Paul Zimmet's view on Apollo's oral insulin
Bill Moss AM
Non-Executive Director and
Investor
"Apollo has a number of opportunities to grow into the future. Opportunities perhaps that are much greater than many other companies many times their size"
Click here to hear Bill Moss's view on investing in Apollo
Corporate Governance

The Directors are responsible for the strategic direction of Apollo, the identification and implementation of corporate policies and goals, and monitoring of the business and affairs of Apollo on behalf of its shareholders.

Apollo is cognisant of the Principles of Good Corporate Governance and Best Practice Recommendations as published by the ASX Corporate Governance Council (ACGC) and acknowledges that the ten principles set out therein are fundamental to good corporate governance. The Board complies with ASX listing rule 4.10 which requires Apollo to provide a statement in its annual return disclosing the extent to which those best practices are followed in any reporting period and to identify any recommendations not followed and provide reasons for any recommendations not being followed.

The Board believes that the structure of Apollo, its management and business practices are appropriate for its size and provides a basis of governance which meets the essential corporate governance principles articulated by ACGC in that publication.

One of the key objectives of the Board is to ensure timely, transparent and accurate communications with all shareholders and compliance with all regulatory requirements. As a result, the Board has established an audit and risk committee and a remuneration committee.

Board of Directors

The Board comprises three executive directors and three non-executive directors. The terms and conditions relating to the appointment and retirement of directors are determined on an individual basis and in conformity with ASX listing rules and the requirements of the Corporations Act 2001.

Audit and Risk Committee
The Board has established an audit and risk committee whose primary function is to monitor and review Apollo's internal financial controls and the integrity of Apollo's financial statements.

Click here to view Apollo Audit and Risk Committee charter

Remuneration Committee
The Board has established a remuneration committee to review and report to the Board on matters concerning executives' and directors' remuneration.

Click here to view Apollo Remuneration Committee charter

Scientific Advisory Panel
Professor Antony Basten, the chair of the Scientific Advisory Panel, liaises with the Scientific Director and is a non-executive director.

Ethical Standards

The directors recognise the need for the company and its employees to observe the highest standards of behaviour and business ethics when engaging in corporate activities.

A key element of this behaviour is the requirement for directors and employees to act with propriety when dealing in the company’s securities.

 
Click here to view Apollo Continuous Disclosure Policy
Click here to view Apollo Share Trading Policy